The delivery of antimicrobial agents to the site of infection has alwa
ys been considered important. Lung infections are typically localized
to the bronchial mucosa, endothelial Lining fluid, and/or alveolar mac
rophages. Significant advances have been made in measuring antimicrobi
al concentrations at these sites, although same of the methods need fu
rther refinement and standardization. Relating various intrapulmonary
site concentrations to efficacy or treatment failure requires further
study. This article reviews the theory and methods relating to the mea
surement of intrapulmonary delivery of antimicrobial agents, and compa
res the intrapulmonary delivery of agents commonly used for the treatm
ent of lower respiratory infections.